Intravesical gentamicin instillation in the prevention of recurrent urinary tract infections in children with neurogenic bladder- a single-center retrospective observational study

Published:September 22, 2022DOI:



      Recurrent urinary tract infections (UTI) in children with neurogenic bladder (NGB) put them at high risk of morbidity and mortality from urosepsis and end-stage renal disease (ESRD). Since the efficacy of low-dose prophylactic antibiotics to prevent these recurrences has been declining since the emergence of extended-spectrum beta-lactamase (ESBL) organisms, intravesical gentamicin instillation has also been used, but only scarce data in children is available in the literature.


      We evaluate the efficacy of intravesical gentamicin instillation to reduce UTIs in children with NGB, compare it with oral antibiotic prophylaxis and determine its effect on pathogens resistance to antibiotics.

      Study design

      Retrospective observational study of 17 children with NGB managed in a tertiary center. Intravesical gentamicin instillation followed an initial period of oral antibiotic prophylaxis. In a conditional negative binomial regression model, a matched comparison of the rate of UTIs, the identified pathogens and their antibiotics susceptibility between the two therapies was performed for each individual child,


      When compared to antibiotic prophylaxis, intravesical gentamicin instillation showed no significant difference in the yearly rate of UTI, symptomatic UTI, or admissions for intravenous antibiotic therapy. However, it was associated with a 38% reduction in the incidence rate ratio of UTI (p = 0.04) and 75% of asymptomatic UTI (p = 0.006) After intravesical gentamicin instillation, five children (31%) had a gentamicin-resistant UTI, similar to before that treatment (p = 0.76).


      Although the overall rate of UTI and of asymptomatic infections were significantly lower with intravesical gentamicin instillation than during oral antibiotic therapy, there was no significant difference in the rate of symptomatic UTIs or UTIs requiring admissions, probably because of the small sample size. In addition, neither an emergence of ESBL pathogens nor the rate of pathogens resistance to gentamicin was observed with intravesical gentamicin instillation. As to the potential nephrotoxicity of aminoglycosides, the calculated GFR for all children remained normal. Strengths of our study include the use of a matched paired comparison of each participant with him/herself with each treatment modality, thus eliminating potential confounding by some individual characteristics. In addition, and unlike previous studies, we have also used a robust multivariate statistical analysis to compare counts and rates of outcomes. Limitations include the absence of gentamicin serum levels monitoring, of hearing testing, and also the small sample size.


      Intravesical gentamicin instillation decreases the overall rate of UTI and asymptomatic infections in children with NGB without increasing the rate of bacterial resistance to gentamicin.



      UTI (Urinary Tract Infection), NGB (Neurogenic bladder), CIC (Clean Intermittent Catheterization), ESRD (End Stage Renal Disease), ESBL (Extended-Release Beta-Lactamase), PO (Per Os), IV (Intravenous)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Stein R.
        • Dogan H.S.
        • Hoebeke P.
        • Kocvara R.
        • Nijman R.J.
        • Radmayr C.
        • et al.
        Urinary tract infections in children: EAU/ESPU guidelines.
        Eur Urol. 2015; 67: 546-558
        • McKibben M.J.
        • Seed P.
        • Ross S.S.
        • Borawski K.M.
        Urinary tract infection and neurogenic bladder.
        Urol Clin North Am. 2015; 42: 527-536
        • Marei M.M.
        • Jackson R.
        • Keene D.J.B.
        Intravesical gentamicin instillation for the treatment and prevention of urinary tract infections in complex paediatric urology patients: evidence for safety and efficacy.
        J Pediatr Urol. 2021; 17: 65 e1-e11
        • Abrams P.
        • Hashim H.
        • Tomson C.
        • Macgowan A.
        • Skews R.
        • Warren K.
        The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunction.
        Neurourol Urodyn. 2017; 36: 2109-2116
        • Cox L.
        • He C.
        • Bevins J.
        • Clemens J.Q.
        • Stoffel J.T.
        • Cameron A.P.
        Gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on intermittent catheterization.
        Can Urol Assoc J. 2017; 11: E350-E354
        • Schwartz G.J.
        • Work D.F.
        Measurement and estimation of GFR in children and adolescents.
        Clin J Am Soc Nephrol. 2009; 4: 1832-1843
        • Anderson R.U.
        Prophylaxis of bacteriuria during intermittent catheterization of the acute neurogenic bladder.
        J Urol. 1980; 123: 364-366
        • Pietropaolo A.
        • Jones P.
        • Moors M.
        • Birch B.
        • Somani B.K.
        Use and effectiveness of antimicrobial intravesical treatment for prophylaxis and treatment of recurrent urinary tract infections (UTIs): a systematic review.
        Curr Urol Rep. 2018; 19: 78
        • Defoor W.
        • Ferguson D.
        • Mashni S.
        • Creelman L.
        • Reeves D.
        • Minevich E.
        • et al.
        Safety of gentamicin bladder irrigations in complex urological cases.
        J Urol. 2006; 175: 1861-1864
        • Wan J.
        • Kozminski M.
        • Wang S.C.
        • Faerber G.J.
        • McGuire E.J.
        • Bloom D.A.
        • et al.
        Intravesical instillation of gentamicin sulfate: in vitro, rat, canine, and human studies.
        Urology. 1994; 43: 531-536
        • de Jong T.P.
        • Donckerwolcke R.A.
        • Boemers T.M.
        Neomycin toxicity in bladder irrigation.
        J Urol. 1993; 150: 1199
        • Dray E.V.
        • Clemens J.Q.
        Recurrent urinary tract infections in patients with incomplete bladder emptying: is there a role for intravesical therapy?.
        Transl Androl Urol. 2017; 6: S163-S170
        • van Nieuwkoop C.
        • den Exter P.L.
        • Elzevier H.W.
        • den Hartigh J.
        • van Dissel J.T.
        Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation.
        Int J Antimicrob Agents. 2010; 36: 485-490
        • Huen K.H.
        • Nik-Ahd F.
        • Chen L.
        • Lerman S.
        • Singer J.
        Neomycin-polymyxin or gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on clean intermittent catheterization.
        J Pediatr Urol. 2019; 15: 178 e1-e7
        • Floyd Jr., M.S.
        • Khadr R.N.
        Role of gentamicin in reducing urinary tract infections in patients with neurogenic bladder.
        Can Urol Assoc J. 2017; 11: 427-428